Endowment Fund Board News: Daniel and Patricia Acosta Fund is Supporting Diversity Initiatives

blog_1.jpg

By Matthew Bogdanffy posted 09-24-2015 13:25

  

Endowment_logo.gif

by Mathew Bogdanffy, 2015–2016 Chair, SOT Endowment Fund Board

The SOT Endowment Fund continues to grow and support the many initiatives and awards to advance the science of toxicology by providing financial support for the Society’s programs. The Endowment Fund includes general purpose funds that support general education, global activities, and strategic priorities of the Society. There are 39 named funds that support travel and educational awards mainly from the Specialty Sections and Special Interest Groups. To ensure sustained support for the initiatives, funds must achieve a balance of $50,000.

Recently, the Daniel and Patricia Acosta Diversity Student Fund crossed the threshold and now is an established permanent fund. “Pat and I are thrilled that the fund has achieved this milestone and has received such generous contributions from our colleagues,” said Dr. Acosta. Currently Deputy Director for Research at FDA's National Center for Toxicological Research and formerly Dean of the University of Cincinnati’s James L. Winkle College of Pharmacy and with the University of Texas College of Pharmacy, Dr. Acosta established the award to encourage individuals from ethnic groups under-represented in the sciences to enter the field of toxicology.

The Daniel and Patricia Acosta Diversity Student Fund aims to fund more students to attend the SOT Undergraduate Education Program, allow for an extended stay during the Annual Meeting, and enable outreach to institutions enrolling under-represented individuals interested in toxicological sciences. This aligns with other fund initiatives and is just one example of how named funds can synergize with other components of the Endowment Fund to further the objectives of the Society. Visit the SOT website for more information about the Endowment Fund and how you can support the initiatives and programs.

0 comments
1 view